Thyrocare Q1 profits jump 34%, revenue up 24%
Thyrocare Technologies reported a strong Q1 FY27 with consolidated revenue of ₹240 crore and net profit of ₹52.2 crore, up from ₹193 crore and ₹38.9 crore a year earlier. The results show consolidated net profit of about ₹52.2 crore on revenue of ₹240 crore, with EBITDA rising to ₹77.3 crore and margins expanding to around 32.2%, signaling healthy operating leverage. On a standalone basis, net profit rose to ₹50.17 crore, while total expenses were around ₹176.59 crore, reflecting improved cost efficiency alongside top-line growth. The board approved the unaudited standalone and consolidated results for Q1 FY27 and re-appointed Ernst & Young LLP as internal auditors for FY2026-27. Thyrocare’s performance underscores sustained momentum in diagnostic testing services within a low-cost, high-volume hub-and-spoke model, aided by franchise additions and B2B partnerships. Overall, the quarter marks robust double-digit growth in both revenue and profitability, strengthening market confidence in the organized diagnostics sector.
Ask this story anything
How it spread
Claim check
What each side asserts, disputes — or leaves out entirely.
Analyzing the coverage…
Where do you land?
Whose framing of this story rings truest to you?